Ready to donate?

You can make and manage your appointments online

Make appointment now


You can call us on

13 14 95

Research advisory committee


Prof Christopher Ward (Chair)

Sydney University Medical School

Professor Ward is the Head, Department of Haematology, Royal North Shore Hospital and Director, Northern Blood Research Centre, overseeing research programmes in platelet function, hypercoagulable states, and global assays of coagulation. His work has led to over 100 peer-reviewed publications. The Centre maintains a busy clinical trials programme and Prof Ward has been principal investigator for many anticoagulant trials. He has received national research awards from the Haematology Society of Australia, Australian Society for Thrombosis and Haemostasis and Royal Australasian College of Pathologists.


A/Prof Robert Andrews

Monash University

Associate Professor Andrews is a Senior Researcher working in the Faculty of Medicine, Nursing & Health Sciences at Monash University. He has more than 180 research publications, and his current research interests include the mechanisms of platelet receptor expression/shedding under shear conditions in vascular systems, von Willebrand factor, and platelet dysfunction in human disease associated with thrombotic or bleeding risk.

He is on the Editorial boards of several journals in the field of thrombosis and haemostasis.


Sandra Cochrane

Executive Director, Fresh Data and Clinical Development, National Blood Authority

Ms Cochrane is the Executive Director from the National Blood Authority (NBA) responsible for managing the Deed of Agreement between the Commonwealth through the National Blood Authority and the Australian Red Cross Society on behalf of the Australian Red Cross Lifeblood. She represents the NBA as a member of the committee to ensure governments’ priorities are considered and to provide guidance on the requirements of governments.


Dr James Daly

QML Pathology

Dr James Daly is a clinical and laboratory haematologist with joint fellowship of RACP and RCPA. He is the President of the ANZSBT and a member of the ANZSBT Transfusion Science Standing Committee, the National Blood Transfusion Committee, the National Haemovigilance Advisory Committee, the Patient Blood Management Steering Committee, the RCPA Haematology Advisory Committee, and the RACP AMD council.


Dr Dana Devine

Chief Medical and Scientific Officer at Canadian Lifeblood

Dr Devine is a Professor of Pathology & Laboratory Medicine at the University of British Columbia. Dr Devine has a longstanding research career in blood products, transfusion medicine, platelet biology, complement biochemistry and coagulation, and has published over 200 peer-reviewed publications. As a member of the BEST Collaborative, she is the co-lead of the conventional components section.

She is the Editor-in-Chief of the blood transfusion journal “Vox Sanguinis.” In service to the transfusion community, Dr Devine is a member of numerous medical/scientific advisory committees and boards including the American Red Cross, Blood Systems Research Institute, Bloodworks Northwest, the New York Blood Center and the Australian Red Cross Lifeblood. Dr Devine is a fellow of the Canadian Academy of Health Sciences as well as recipient of the Queen’s Golden Jubilee Award and the 2015 Ortho Award of the Canadian Society for Transfusion Medicine.


Larry Dumont, MBA, PhD

Director, Center for Transfusion Medicine Research

Dr Dumont  is currently Associate Professor of Pathology and director of the Center for Transfusion Medicine Research, Dartmouth-Hitchcock Medical Center.
He spent 27 years at GAMBRO BCT in various technical capacities. He has been actively involved with the Biomedical Excellence for Safer Transfusion Collaborative (BEST) for 22 years, and is the immediate past Chair of BEST.


Dirk de Korte PhD

Blood Cell Research, Sanquin

Dirk de Korte is Manager Product and Process Development of Sanquin Blood Bank and Principal Investigator at Dept of Blood Cell Research at Sanquin Research, Netherlands. He has over 150 peer-reviewed research publications and his special interests are in vitro quality parameters for the evaluation of blood components, optimal use of blood products, development and improvement of blood components for transfusion and bacteriological safety of blood components.

He is a scientific member of the BEST collaborative, Conventional Components Team and a scientific member of the ISBT Working Party Transfusion Transmitted Infections. He is also member of the Standard Advisory Committee Blood Components of NHSBT (UK). Dirk de Korte is representative for the Netherlands in the Working Group on Guide to the Presentation, Use and QA of Blood Components of the Council of Europe.


Professor John McNeil AM

Sir John Monash Distinguished Professor, Head of School of Public Health and Preventive Medicine, Monash University

Professor McNeill AM has been the Head of the Monash University School of Public Health and Preventive Medicine based at the Alfred Hospital since 1986. He is a member of numerous boards, including the Victorian Managed Insurance Authority and Austin Health.

In 2008 he was awarded an AM for services to Public Health.  In 2014 he received a Sir John Monash Distinguished Professorship.


Prof Sally Redman AO

Sax Institute

Professor Redman has extensive experience in public health research, particularly evaluation of programs designed to improve health and healthcare. She is an inaugural Director of the National Breast Cancer Centre and received the Centenary Medal for service to women diagnosed with breast cancer.


Dr Yahya Shehabi

Monash University

Dr Shehabi is Professor of Medicine, Faculty Medicine, Nursing and Health Sciences, Monash University and a Conjoint Professor Intensive Care Medicine at the Clinical School of University of New South Wales. He is current Professor and Director for Critical Care and Perioperative Medicine Research, Monash Health and Theme Lead at the Monash Health Translational Research Precinct.

His qualifications include PhD from the University of New South Wales, Master of Executive Business Administration (EMBA) and a Graduate Diploma of the Australian Institute of Company Directors (GAICD). His past roles include the Chair NSW CICM Regional Committee, the PRICE ANZICS committee, Director at the ANZICS Board and Chairman Intensive Care Foundation.

Back to top